Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

During the Trading Day
10.63 -0.48 / -4.32%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
10.67 +0.0401 / +0.38%
 
Volume: 5.4K
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$435.0M

Company Description

Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on developing and commercializing products to treat treat serious and life-threatening diseases, including lupus, lupus with glomerulonephritis, IgA nephropathy, and exocrine pancreatic insufficiency due to cystic fibrosis. It developed phase 3 product candidates, which includes blisibimod and liprotamase. Anthera Pharmaceuticals was founded by Paul F. Truex on September 9, 2004 and is headquartered in Hayward, CA.

Contact Information

Anthera Pharmaceuticals, Inc.
25801 Industrial Boulevard
Hayward California 94545
P:(510) 856-5600
Investor Relations:

Employees

Shareholders

Other institutional20.13%
Mutual fund holders14.89%
Individual stakeholders0.63%

Top Executives

Paul F. TruexPresident, Chief Executive Officer & Director
May LiuCAO, Senior VP-Finance & Administration
Colin HislopChief Medical Officer & Senior Vice President
Debra A. OdinkChief Technology Officer & Senior Vice President
Klara A. Dickinson-EasonChief Regulatory Officer & Senior Vice President